PTK2 and mantle cell lymphoma: Focal adhesion kinase (FAK) is a novel “stromal”-related therapeutic target as a major signaling molecule, highly expressed in MCL, that functions downstream of integrins (including CXCL12) and that translates signals from the extracellular matrix in the bone marrow.